Preparation method of L-phosphinothricin

The preparation process of glufosinate ammonium is simplified by the reaction of L-lactone derivative compounds with halogenating agents and phosphorus-based compounds, and the problems of low yields and complex processes in the prior art are solved, thereby achieving high optical purity and high yields Preparation of L-glufosinate in rate.

CN113316580BActive Publication Date: 2024-11-19CJ CHEILJEDANG CORP
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN201980088509.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-01-15
Filing Date
2019-11-29
Publication Date
2024-11-19
Estimated Expiration
2039-11-29

AI Technical Summary

Technical Problem

The existing methods have low yields and complex processes when preparing the L-isomer of glufosinate, which require separators and separation devices, resulting in complicated processes.

Method used

The process flow was simplified by the one-pot synthesis of L-lactone derivative compounds through specific chemical reaction steps, including the participation of halogenating agents and phosphorus-based compounds.

Benefits of technology

The preparation of L-glufosinate with high yield and high optical purity is achieved, which simplifies the process flow and reduces the process complexity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FDF0000030757960000011
    Figure FDF0000030757960000011
  • Figure FDF0000030757960000021
    Figure FDF0000030757960000021
  • Figure FDF0000030757960000022
    Figure FDF0000030757960000022
Patent Text Reader

Abstract

Provided is a method for preparing L-glufosinate from an L-lactone derivative compound, the method comprising a step of preparing a compound of Chemical Formula 2 from a compound of Chemical Formula 1 (step a) and a step of preparing L-glufosinate of Chemical Formula 3 from the compound of Chemical Formula 2 (step b).
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a method for preparing L-glufosinate-ammonium. Background Art

[0002] Glufosinate-ammonium is widely used as a broad-spectrum herbicide with permeability, and the permeability herbicide characteristic of known glufosinate-ammonium is the effect caused by the L-isomer (isomer) of glufosinate-ammonium. Thus, the various methods for preparing glufosinate-ammonium L-isomer have been studied. For example, a method for preparing glufosinate-ammonium L-isomer by selectively separating the L-isomer from the racemic mixture of D-isomer and L-isomer has been used. The problem with such a method is that the yield of the L-isomer has reduced by half or less, and the unwanted D-isomer as an excessive by-product has been produced, and a separating agent (resolvingagent), a separating device (resolving device) etc. are needed to carry out the separation of the L-isomer, so the process is complicated.

[0003] Therefore, it is necessary to develop a method for preparing glufosinate-ammonium L-isomer with high optical purity in a simple and high yield. Summary of the invention

[0004] Issues to be solved

[0005] The purpose of the present application is to provide a method for preparing L-glufosinate-ammonium with high optical purity in a simple and high yield.

[0006] Solution to the problem

[0007] According to one aspect, a method for preparing L-glufosinate is provided, which is a method for preparing L-glufosinate from an L-lactone derivative compound, comprising: a step of preparing a compound of the following Chemical Formula 2 from a compound of the following Chemical Formula 1 (step a); and a step of preparing L-glufosinate of the following Chemical Formula 3 from the compound of the above Chemical Formula 2 (step b).

[0008] <Chemical Formula 1>

[0009]

[0010] <Chemical Formula 2>

[0011]

[0012] <Chemical formula 3>

[0013]

[0014] In the above formula,

[0015] R1 is R a -(C=O)-, where Ra is hydrogen, substituted or unsubstituted alkyl having 1 to 6 carbon atoms, substituted or unsubstituted alkenyl having 1 to 6 carbon atoms, substituted or unsubstituted alkynyl having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 10 carbon atoms, substituted or unsubstituted aryl having 6 to 20 carbon atoms, or substituted or unsubstituted heteroaryl having 2 to 10 carbon atoms,

[0016] R2 is hydrogen, substituted or unsubstituted alkyl having 1 to 6 carbon atoms, substituted or unsubstituted alkenyl having 1 to 6 carbon atoms, substituted or unsubstituted alkynyl having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 10 carbon atoms, or substituted or unsubstituted aryl having 6 to 20 carbon atoms, substituted or unsubstituted heteroaryl having 2 to 10 carbon atoms, or -Si(R b )(R c )(R d ), where R b , R c and R d are independently a substituted or unsubstituted alkyl group having 1 to 6 carbon atoms, or a substituted or unsubstituted aryl group having 6 to 20 carbon atoms,

[0017] R5 is hydrogen, substituted or unsubstituted alkyl having 1 to 6 carbon atoms, substituted or unsubstituted alkenyl having 1 to 6 carbon atoms, substituted or unsubstituted alkynyl having 1 to 6 carbon atoms,

[0018] The substituents of the above-mentioned alkyl, alkenyl, alkynyl, cycloalkyl, aryl and heteroaryl groups are independently selected from at least one of the group consisting of hydrogen, halogen, carboxyl (-COOH), amino (-NH2), nitro (-NO2), cyano (-CN), alkyl groups having 1 to 6 carbon atoms, aryl groups having 6 to 10 carbon atoms and cycloalkyl groups having 3 to 10 carbon atoms.

[0019] Effects of the Invention

[0020] The method for preparing L-glufosinate according to one embodiment can simply produce L-glufosinate with high optical purity by using a new intermediate compound and having a new synthetic route.

[0021] In addition, L-glufosinate can be prepared in high yield by a simple method. DETAILED DESCRIPTION

[0022] Hereinafter, a method for preparing L-glufosinate-ammonium according to one embodiment will be described in more detail.

[0023] The inventive concept of the present application described below can be modified in various forms and can have various embodiments, so specific embodiments will be described and described in detail. However, the embodiments are not intended to limit the inventive concept of the present application, and it should be understood that the present invention includes all modifications, equivalents and alternatives belonging to the technical scope of the inventive concept of the present application.

[0024] As used herein, terms such as first, second, third, fourth, etc. may be used to describe various elements, but the elements should not be limited by these terms. These terms are only used to distinguish one constituent element from another constituent element.

[0025] As used herein, the term "L-glufosinate" is the L-isomer of glufosinate. As used herein, the term "D-glufosinate" is the D-isomer of glufosinate.

[0026] The term "% enantiomeric excess (% enantiomeric excess: % ee)" refers to the enantiomeric purity of a sample, i.e., the percentage of one enantiomer in a sample that exceeds the other enantiomer. For example, the enantiomeric excess of L-glufosinate is the percentage of L-glufosinate in glufosinate that exceeds D-glufosinate. For example, the enantiomeric excess of L-glufosinate is represented by the following equation 1.

[0027] <Equation 1>

[0028] L-Glufosinate enantiomeric excess = [(L-Glufosinate content - D-Glufosinate content) / (L-Glufosinate content + D-Glufosinate content)] × 100

[0029] According to one embodiment, a method for preparing L-glufosinate is a method for preparing L-glufosinate from an L-lactone derivative compound, comprising: a step of preparing a compound of the following Chemical Formula 2 from a compound of the following Chemical Formula 1 (step a); and a step of preparing L-glufosinate of the following Chemical Formula 3 from the compound of the above Chemical Formula 2 (step b).

[0030] <Chemical Formula 1>

[0031]

[0032] <Chemical Formula 2>

[0033]

[0034] <Chemical formula 3>

[0035]

[0036] In the above formula,

[0037] R1 is R a-(C=O)-, where R a is hydrogen, substituted or unsubstituted alkyl having 1 to 6 carbon atoms, substituted or unsubstituted alkenyl having 1 to 6 carbon atoms, substituted or unsubstituted alkynyl having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 10 carbon atoms, substituted or unsubstituted aryl having 6 to 20 carbon atoms, or substituted or unsubstituted heteroaryl having 2 to 10 carbon atoms,

[0038] R2 is hydrogen, substituted or unsubstituted alkyl having 1 to 6 carbon atoms, substituted or unsubstituted alkenyl having 1 to 6 carbon atoms, substituted or unsubstituted alkynyl having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 10 carbon atoms, or substituted or unsubstituted aryl having 6 to 20 carbon atoms, substituted or unsubstituted heteroaryl having 2 to 10 carbon atoms, or -Si(R b )(R c )(R d ), where R b , R c and R d are independently a substituted or unsubstituted alkyl group having 1 to 6 carbon atoms, or a substituted or unsubstituted aryl group having 6 to 20 carbon atoms,

[0039] R5 is hydrogen, substituted or unsubstituted alkyl having 1 to 6 carbon atoms, substituted or unsubstituted alkenyl having 1 to 6 carbon atoms, or substituted or unsubstituted alkynyl having 1 to 6 carbon atoms,

[0040] The substituents of the above-mentioned alkyl, alkenyl, alkynyl, cycloalkyl, aryl and heteroaryl groups are independently selected from at least one of the group consisting of hydrogen, halogen, carboxyl (-COOH), amino (-NH2), nitro (-NO2), cyano (-CN), alkyl groups having 1 to 6 carbon atoms, aryl groups having 6 to 10 carbon atoms and cycloalkyl groups having 3 to 10 carbon atoms.

[0041] More specifically, step a may include a step of preparing a compound of the following Chemical Formula 4 by reacting the compound of Chemical Formula 1 with a halogenation agent and at least one R2-OH (step c).

[0042] <Chemical Formula 4>

[0043]

[0044] In the above formula, R1 and R2 are as defined above, and X is halogen.

[0045] That is, the first intermediate compound represented by Chemical Formula 4 can be prepared by reacting the compound of Chemical Formula 1 with a halogenating agent and at least one R2-OH. For example, the second intermediate compound can be formed by reacting the lactone compound represented by Chemical Formula 1 with the halogen of the halogenating agent to perform a ring opening reaction, and then performing a substitution reaction with the R2-functional group of the R2-OH compound.

[0046] <Chemical Formula 1>

[0047]

[0048] <Chemical Formula 4>

[0049]

[0050] In the compound of Chemical Formula 1 and the first intermediate compound represented by Chemical Formula 4, for example, R1 may be an acetyl group or a succinyl group, and R2 may be a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group, a hexyl group, a benzyl group, a phenyl group, a naphthyl group, -Si(CH3)(tert-butyl)2, -Si(C6H5)2(tert-butyl), -Si(isopropyl)3, -Si(C5H6)(CH3)2, -Si(C6H5)2(CH3), -Si(C5H6)3, -Si(CH3)3, -Si(CH2CH3)3, -Si(CH2CH3)2(CH3), -Si(CH2CH3)(CH3)2, or -Si(tert-butyl)3. Since the compound of Chemical Formula 1 and the first intermediate compound represented by Chemical Formula 4 have such functional groups, L-phosphinothricin with improved optical purity can be more easily prepared.

[0051] The compound of Chemical Formula 1 can be prepared, for example, from a fermentation broth containing a precursor of the compound of Chemical Formula 1. Therefore, L-phosphinothricin can be effectively prepared by using a compound of Chemical Formula 1 derived from a precursor of the compound of Chemical Formula 1 produced during fermentation. The precursor of the compound of Chemical Formula 1 can be, for example, an L-homoserine derivative. The L-homoserine derivative can be, for example, O-acetyl-L-homoserine, O-succinyl-L-homoserine, etc., which are O-substituted forms of L-homoserine. For example, an L-homoserine derivative as a precursor of the first intermediate compound can be separated from the fermentation broth, and the separated L-homoserine derivative can be subjected to a cyclization reaction to prepare the compound of Chemical Formula 1.

[0052] Furthermore, by using an intermediate compound derived from an O-substituted L-homoserine derivative, there is no need to use an additional material to introduce an amino protecting group, and L-phosphinothricin can be prepared in a one pot process in which all reactions are carried out in one reactor, thus being highly efficient.

[0053] As used herein, the term "fermentation broth containing a precursor of the compound of Formula 1" may be a fermentation broth containing a precursor of the compound of Formula 1 produced by a fermentation process. The fermentation broth may be a fermentation broth obtained by culturing a microorganism in a medium containing sugar, or alternatively, may be a fermentation broth obtained by culturing a microorganism by enzymatic conversion. For example, the fermentation broth containing the precursor of the compound of Formula 1 may be a fermentation broth in which the precursor of the compound of Formula 1 is directly produced by culturing a microorganism in a medium containing sugar, or a fermentation broth containing the precursor of the compound of Formula 1 obtained by enzymatic conversion of an amino acid produced by culturing a microorganism in a sugar-containing medium. The type of microorganism used to prepare the fermentation broth containing the precursor of the compound of Formula 1 is not particularly limited, and any microorganism in the art that can produce an L-homoserine derivative by direct fermentation or enzymatic conversion may be used. The fermentation broth containing the L-homoserine derivative can be, for example, a fermentation broth obtained by fermenting a culture medium containing the O-succinyl-L-homoserine producing strain CJM-BTJ / pCJ-MetA-CL (Accession No.: KCCM-10872) disclosed in Example 2 of KR 10-2014-0116010 or the O-acetyl-L-homoserine producing strain CJM-BTJA / pCJ-MetX-CL (Accession No.: KCCM-10873).

[0054] The halogenating agent may include at least one selected from the group consisting of, for example, SOCl2, oxalyl chloride, triethylsilane ((CH2CH3)3SiH)+palladium chloride (PdCl2)+methyl iodide (CH3I), POCl3, PCl3, PCl5, PBr3, PI3, H2SO4+KBr, P+Cl2, P+Br2, P+I2, TiCl4, ZnCl2, and BBr3. The halogenating agent may be, in particular, triethylsilane ((CH2CH3)3SiH)+palladium chloride (PdCl2)+methyl iodide (CH3I) or SOCl2, etc.

[0055] The content of the halogenating agent may be, for example, 1 to 10 equivalents, 1 to 5 equivalents, 1 to 4 equivalents, 1 to 3 equivalents, 1 to 2 equivalents, 1 to 1.5 equivalents, 0.1 to 1.3 equivalents, or 1 to 1.1 equivalents based on 1 equivalent of the compound represented by Chemical Formula 1.

[0056] At least one R2-OH compound can be used to react to form the first intermediate compound. When multiple R2-OH compounds are used, the individual R2-OH compounds can be the same or different from each other.

[0057] The R2-OH compound can be, for example, at least one selected from the group consisting of methanol, ethanol, n-propanol, isopropanol, butanol, pentanol, hexanol, benzyl alcohol, phenol and naphthol. By selecting the above materials as the R2-OH compound, the first intermediate compound can be obtained from the compound of Chemical Formula 1 with a higher yield.

[0058] Based on 1 equivalent of the compound of Chemical Formula 1, the content of the R2-OH compound can be, for example, 1 to 60 equivalents, 1 to 40 equivalents, 2 to 20 equivalents, or 3 to 10 equivalents. The step of preparing the second intermediate compound can be carried out in the presence of a solvent, or can be carried out under neat conditions without a solvent. The solvent can be an organic solvent.

[0059] The organic solvent may be, for example, alcohol, toluene, benzene, tetrahydrofuran, acetone, chloroform, dichloromethane, acetonitrile, etc., but is not limited thereto, and any solvent used together with a halogenating agent in the art may be used. Alcohol may be, for example, methanol, ethanol, propanol, butanol, amyl alcohol, etc., but is not limited thereto.

[0060] In the step of preparing the first intermediate compound, the halogenation reaction (halogenation) / ring-opening reaction is carried out at a temperature of, for example, 20 to 100 ° C, 20 to 80 ° C, 30 to 70 ° C or 40 to 60 ° C. In the step of preparing the first intermediate compound, the ring-opening reaction and / or substitution reaction can be carried out for example 0.1 to 30 hours, 1 to 30 hours, 5 to 30 hours, 10 to 30 hours, 15 to 25 hours, 17 to 23 hours or 18 to 20 hours. Due to the halogenation reaction and the ring-opening reaction in the above temperature range and time range, the first intermediate compound can be prepared more easily.

[0061] In the step of preparing the first intermediate compound, the yield of the first intermediate compound can be, for example, 10% or more, 20% or more, 30% or more, 40% or more, 50% or more, 60% or more, 70% or more, 80% or more, 90% or more, 95% or more, 96% or more, 97% or more, 98% or more, or 99% or more.

[0062] In the step of preparing the first intermediate compound, the enantiomeric excess of the first intermediate compound having the L form may be, for example, 10% ee or more, 20% ee or more, 30% ee or more, 40% ee or more, 50% ee or more, 60% ee or more, 70% ee or more, 80% ee or more, 90% ee or more, 91% ee or more, 92% ee or more, 93% ee or more, 94% ee or more, 95% ee or more, 96% ee or more, 97% ee or more, 98% ee or more, or 99% ee or more.

[0063] Then, step a may include a step of preparing a compound of Chemical Formula 2 by reacting the compound of Chemical Formula 4 with a compound of the following Chemical Formula 5 after step c (step d).

[0064] <Chemical Formula 5>

[0065]

[0066] In the above formula, R3 and R4 are independently hydrogen, substituted or unsubstituted alkyl having 1 to 6 carbon atoms, substituted or unsubstituted alkenyl having 1 to 6 carbon atoms, or substituted or unsubstituted alkynyl having 1 to 6 carbon atoms.

[0067] Next, in the step of preparing the second intermediate compound represented by Chemical Formula 2, the second intermediate compound represented by the following Chemical Formula 2 may be prepared by reacting the first intermediate compound and the first acid with a phosphorus-based compound represented by the following Chemical Formula 5, or by reacting the first intermediate compound with the phosphorus-based compound represented by Chemical Formula 5 without the first acid. That is, the second intermediate compound represented by Chemical Formula 2 may be prepared by reacting the compound of Chemical Formula 4 with a phosphorus-based compound.

[0068] <Chemical Formula 4>

[0069]

[0070] <Chemical Formula 5>

[0071]

[0072] <Chemical Formula 2>

[0073]

[0074] In the first intermediate compound represented by Chemical Formula 4, the phosphorus-based compound represented by Chemical Formula 5, and the second intermediate compound represented by Chemical Formula 2, for example, R1 may be an acetyl group or a succinyl group, R2 may be a hydrogen, a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group, a hexyl group, a benzyl group, a phenyl group, a naphthyl group, -Si(CH3)(tert-butyl)2, -Si(C6H5)2(tert-butyl), -Si(isopropyl)3, -Si(C5H6)(CH3)2, -Si(C6H5)2(CH3), -Si(C5H6)3, -Si(CH3)3, -Si(CH2CH3)3, -Si(CH2CH3)2(CH3), -Si(CH2CH3)(CH3)2, or -Si(tert-butyl)3, R3 and R4 may be independently any one selected from the group consisting of a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group, and a hexyl group, and R5 may be R3 or R4. Since the first intermediate compound represented by Chemical Formula 4, the phosphorus-based compound represented by Chemical Formula 5, and the second intermediate compound represented by Chemical Formula 2 have such functional groups, L-glufosinate with improved optical purity can be more easily prepared.

[0075] The phosphorus compound represented by Chemical Formula 5 may be, in particular, an alkylmethylphosphonite, such as diethylmethylphosphonite (DMP), ethylmethylphosphinate (EMP), or butylmethylphosphinate (BMP).

[0076] The phosphorus-based compound represented by Chemical Formula 5 may be used in an amount of 0.5 to 10 equivalents, 0.7 to 8 equivalents, 0.9 to 7 equivalents, or 1 to 6 equivalents, based on 1 equivalent of the first intermediate compound represented by Chemical Formula 4.

[0077] The first acid is, for example, a Lewis acid, which may be, for example, at least one selected from KF+Al2O3, ZnCl2 LiBr, ZnBr2, BF3-Et2O (diethyl ether), COCl2, MgBr2, Bu3P, Sc(OTf)3 (OTf=trifluoromethanesulfonate), Sc(NTf2)3 (scandium(III) trifluoromethanesulfonyl imide), TiCl3-2AgClO4, TiCl3(OTf), Sn(OTf)2, TMSOTf (trimethylsilyl trifluoromethanesulfonate), La(OTf)3, Cu(OTf)2 and TaCl5, in particular, it may be KF+Al2O3.

[0078] The content of the first acid may be, for example, 0.1 to 100 parts by weight, 0.1 to 50 parts by weight, 0.1 to 40 parts by weight, 0.1 to 30 parts by weight, 0.1 to 20 parts by weight, 0.1 to 10 parts by weight, 0.1 to 5 parts by weight, or 0.1 to 2 parts by weight, based on 100 parts by weight of the compound represented by Chemical Formula 4. When the content of the first acid is too low, the reaction rate may be little affected, while when the content of the first acid is too high, by-products may increase.

[0079] By using the first acid, the second intermediate compound can be obtained with a further improved yield. In the step of preparing the second intermediate compound, the reaction can be carried out at a temperature of, for example, 80 to 180 ° C, 80 to 160 ° C, 90 to 160 ° C, 90 to 150 ° C, 100 to 160 ° C, 100 to 150 ° C, 100 to 140 ° C, 110 to 160 ° C, 110 to 150 ° C, 110 to 160 ° C, 110 to 140 ° C, 120 to 160 ° C, 120 to 150 ° C or 120 to 140 ° C. On the other hand, when acid is added, the reaction temperature can be, for example, 80 to 160 ° C, and when acid is not added, the reaction time can be increased, and the reaction temperature can be raised. For example, when acid is not used, the reaction temperature can be 120 to 180 ° C. In the step of preparing the second intermediate compound, the reaction can be carried out for example 0.1 to 20 hours, 1 to 20 hours, 1 to 18 hours, 5 to 15 hours, 6 to 14 hours, 8 to 14 hours, 10 to 14 hours or 11 to 13 hours. Since the reaction is carried out within the above temperature range and time range, the second intermediate compound can be prepared more easily.

[0080] In the step of preparing the second intermediate compound, the yield of the second intermediate compound can be, for example, 10% or more, 20% or more, 30% or more, 40% or more, 50% or more, 60% or more, 70% or more, 80% or more, 90% or more, 95% or more, 96% or more, 97% or more, 98% or more, or 99% or more.

[0081] In the step of preparing the second intermediate compound, the enantiomeric excess of the second intermediate compound having the L form may be, for example, 10% ee or more, 20% ee or more, 30% ee or more, 40% ee or more, 50% ee or more, 60% ee or more, 70% ee or more, 80% ee or more, 90% ee or more, 91% ee or more, 92% ee or more, 93% ee or more, 94% ee or more, 95% ee or more, 96% ee or more, 97% ee or more, 98% ee or more, or 99% ee or more.

[0082] According to one embodiment, step a may include a step of preparing a compound of Chemical Formula 2 by reacting the compound of Chemical Formula 1 with a halogenating agent, at least one R2-OH and a compound of the following Chemical Formula 5 (step a-1).

[0083] <Chemical Formula 5>

[0084]

[0085] In the above formula, R3 and R4 are independently hydrogen, substituted or unsubstituted alkyl having 1 to 6 carbon atoms, substituted or unsubstituted alkenyl having 1 to 6 carbon atoms, or substituted or unsubstituted alkynyl having 1 to 6 carbon atoms.

[0086] Specifically, R1 may be an acetyl group or a succinyl group, and R2-OH may be at least one selected from the group consisting of methanol, ethanol, n-propanol, isopropanol, butanol, amyl alcohol, hexanol, benzyl alcohol, phenol, and naphthol. Further, R3 and R4 may include any one selected from the group consisting of methyl, ethyl, propyl, butyl, amyl, and hexyl. Since the compound of Chemical Formula 1, the phosphorus-based compound represented by Chemical Formula 5, and the second intermediate compound represented by Chemical Formula 2 have such functional groups, L-phosphinothricin with improved optical purity can be prepared more easily.

[0087] The phosphorus-based compound represented by Chemical Formula 5 may be, in particular, an alkyl methylphosphite, such as diethyl methylphosphite (DMP), ethyl methylphosphite (EMP), or butyl methylphosphite (BMP).

[0088] The phosphorus-based compound represented by Chemical Formula 5 may be used in an amount of 0.5 to 10 equivalents, 0.7 to 8 equivalents, 0.9 to 7 equivalents, or 1 to 6 equivalents, based on 1 equivalent of the compound of Chemical Formula 1.

[0089] The halogenating agent may include, for example, at least one selected from the group consisting of HCl, HBr, HI, phosgene, SOCl2, oxalyl chloride, trimethylsilyl halide, sodium iodide (NaI), triethylsilane ((CH2CH3)3SiH)+palladium chloride (PdCl2)+methyl iodide (CH3I), POCl3, PCl3, PCl5, PBr3, PI3, H2SO4+KBr, P+Cl2, P+Br2, P+I2, TiCl4, ZnCl2 and BBr3.

[0090] In the step of preparing the second intermediate compound by reacting the compound of Chemical Formula 1 with a halogenating agent, at least one R2-OH compound and a phosphorus-based compound, the halogenating agent may be, in particular, trimethylsilyl halide, sodium iodide (NaI), etc. The content of the halogenating agent may be, for example, 0.1 to 10 equivalents, 0.2 to 8 equivalents, 0.3 to 6 equivalents, or 0.5 to 5 equivalents based on 1 equivalent of the compound of Chemical Formula 1.

[0091] At least one R2-OH compound can be used to react to form the second intermediate compound. When multiple R2-OH compounds are used, the individual R2-OH compounds can be the same or different from each other.

[0092] The R2-OH compound can be, for example, at least one selected from the group consisting of methanol, ethanol, n-propanol, isopropanol, butanol, pentanol, hexanol, benzyl alcohol, phenol and naphthol. By selecting the above materials as the R2-OH compound, the second intermediate compound can be obtained from the compound of Chemical Formula 1 with a higher yield.

[0093] The content of the R2-OH compound may be, for example, 1 to 60 equivalents, 1 to 40 equivalents, 2 to 20 equivalents, or 3 to 10 equivalents, based on 1 equivalent of the compound of Chemical Formula 1.

[0094] When the second intermediate compound represented by Chemical Formula 2 is prepared using the compound of Chemical Formula 1, the halogenating agent, and the phosphorus-based compound of Chemical Formula 5, the reaction may be performed at, for example, 80 to 180° C., 80 to 160° C., 90 to 160° C., 90 to 150° C., 100 to 160° C., 100 to 150° C., 100 to 140° C., 110 to 160° C., 110 to 150° C., 110 to 160° C., 110 to 140° C., 120 to 160° C., 120 to 150° C., or 120 to 140° C. The reaction may be performed specifically for 0.1 to 20 hours.

[0095] The specific reaction conditions refer to the step of preparing the second intermediate compound represented by Chemical Formula 2 from the compound of Chemical Formula 1 above.

[0096] In the step of preparing the second intermediate compound, the yield of the second intermediate compound and the enantiomeric excess of the second intermediate compound having the L form are the same as described above.

[0097] According to one embodiment, step b of preparing L-glufosinate of Chemical Formula 3 from the compound of Chemical Formula 2 can be performed by hydrolyzing the compound of Chemical Formula 2 under an acid catalyst. That is, the second intermediate compound of Chemical Formula 4 can react with a second acid (acid catalyst) to remove the terminal functional group by hydrolysis, thereby preparing L-glufosinate represented by Chemical Formula 3.

[0098] The second acid may be, for example, at least one selected from the group consisting of HCl, H2SO4, and a combination of KF and Al2O3 (KF+Al2O3), but the second acid is not limited thereto, and the second acid may be used without limitation as long as the second acid is used as an acid catalyst in the art. The second acid may be, in particular, hydrochloric acid.

[0099] The content of the second acid may be, for example, 0.1 to 100 parts by weight, 0.1 to 50 parts by weight, 0.1 to 40 parts by weight, 0.1 to 30 parts by weight, 0.1 to 20 parts by weight, 0.1 to 10 parts by weight, 0.1 to 5 parts by weight, or 0.1 to 2 parts by weight, based on 100 parts by weight of the second intermediate compound represented by Chemical Formula 2. When the content of the second acid is too low, the reaction rate may be little affected, while when the content of the second acid is too high, by-products may increase.

[0100] When the solvent is water when the second acid is used, the pH value of the aqueous solution may be 1 to 3. That is, in the step of preparing the fourth intermediate compound, the reaction solution may be an acidic aqueous solution with a pH value of 1 to 3. Since the pH value of the reaction solution is within this range, the fourth intermediate compound can be prepared more easily.

[0101] In the step of preparing L-glufosinate, the hydrolysis reaction can be carried out at a temperature of, for example, 20 to 150° C., 40 to 140° C., 60 to 130° C., 80 to 120° C. or 90 to 110° C. In the step of preparing L-glufosinate, the hydrolysis reaction can be carried out for example 0.1 to 30 hours, 1 to 20 hours, 1 to 15 hours, 3 to 13 hours, 4 to 12 hours, 5 to 11 hours, 6 to 10 hours, 7 to 9 hours, 10 to 30 hours, 12 to 24 hours, 15 to 20 hours or 15 to 18 hours. Since the hydrolysis reaction is carried out in the above-mentioned temperature range and time range, L-glufosinate can be prepared more easily.

[0102] In the step of preparing L-glufosinate, the yield of L-glufosinate can be, for example, 10% or more, 20% or more, 30% or more, 40% or more, 50% or more, 60% or more, 70% or more, 80% or more, 90% or more, 95% or more, 96% or more, 97% or more, 98% or more, or 99% or more.

[0103] The enantiomeric excess of the L-grass ammonium phosphine prepared can be, for example, 10%ee or higher, 20%ee or higher, 30%ee or higher, 40%ee or higher, 50%ee or higher, 60%ee or higher, 70%ee or higher, 80%ee or higher, 90%ee or higher, 91%ee or higher, 92%ee or higher, 93%ee or higher, 94%ee or higher, 95%ee or higher, 96%ee or higher, 97%ee or higher, 98%ee or higher, or 99%ee or higher. For example, because L-grass ammonium phosphine has such an improved optical purity, a further improved herbicide effect can be provided.

[0104] In the present invention, L-glufosinate may include its salt form. Specifically, the salt of L-glufosinate may be, for example, the hydrochloride of L-glufosinate, the sulfate of L-glufosinate, the carbonate of L-glufosinate, the ammonium salt of L-glufosinate, etc., but is not necessarily limited thereto, and the salt may be used without restriction, as long as it is the salt of L-glufosinate obtained by the above-mentioned glufosinate preparation method.

[0105] According to the present invention, by using the synthetic route of the first intermediate compound of Chemical Formula 1, L-phosphinothricin having high optical purity can be prepared simply and in high yield.

[0106] In addition, the compound of Chemical Formula 1 can be prepared by reacting an L-homoserine derivative represented by the following Chemical Formula 6 with a first base to prepare a third intermediate compound represented by the following Formula 7, and then reacting the third intermediate compound with a third acid. That is, before step a or step a-1, the method may further include a step of preparing a third intermediate compound represented by Chemical Formula 7 by reacting an L-homoserine derivative represented by the following Chemical Formula 6 with a first base; and a step of preparing a compound of Chemical Formula 1 by reacting the third intermediate compound with a third acid.

[0107] More specifically, the L-homoserine derivative represented by the following Chemical Formula 6 may react with a first base to prepare a third intermediate compound represented by the following Chemical Formula 7.

[0108] In the L-homoserine derivative represented by Chemical Formula 6, R represented by R1 a The (C=O)-functional group can be combined with nitrogen in the third intermediate compound represented by Chemical Formula 7 through a functional group transfer reaction under a first base catalyst. For example, in the L-homoserine derivative represented by Chemical Formula 6, the functional group represented by R1 can be combined with nitrogen in the third intermediate compound represented by Formula 7 through a functional group transfer reaction under a first base, thereby playing a role as a protecting group of amine.

[0109] <Chemical Formula 6>

[0110]

[0111] <Chemical Formula 7>

[0112]

[0113] In the above formula,

[0114] R1 is Re-(C=O)-, wherein Re is a substituted or unsubstituted alkyl group having 1 to 6 carbon atoms, a substituted or unsubstituted alkenyl group having 1 to 6 carbon atoms, a substituted or unsubstituted alkynyl group having 1 to 6 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 10 carbon atoms, a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, or a substituted or unsubstituted heteroaryl group having 2 to 10 carbon atoms, and the substituents of the above alkyl, alkenyl, alkynyl, cycloalkyl, aryl and heteroaryl groups are independently selected from at least one of halogen, carboxyl (-COOH), amino (-NH2), nitro (-NO2), cyano (-CN), alkyl groups having 1 to 6 carbon atoms, aryl groups having 6 to 10 carbon atoms and cycloalkyl groups having 3 to 10 carbon atoms.

[0115] In the L-homoserine derivative represented by Chemical Formula 6, for example, R1 may be an acetyl group or a succinyl group. Since the L-homoserine derivative represented by Chemical Formula 6 has such a functional group, L-phosphinothricin with improved optical purity may be more easily prepared.

[0116] The L-homoserine derivative represented by Chemical Formula 6 can be prepared, for example, from a fermentation broth containing the L-homoserine derivative. Therefore, L-phosphinothricin can be efficiently prepared by using the L-homoserine derivative represented by Chemical Formula 6 produced during fermentation.

[0117] As used herein, the term "fermentation broth containing an L-homoserine derivative" may be a fermentation broth containing an L-homoserine derivative produced by a fermentation process. Regarding the fermentation, the same as described above may be used.

[0118] The first base can be, for example, at least one selected from NH3, KOH, NaOH, CaSO4, LiOH, NaH, KH, NaOCH3, NaOCH2CH3, NaOC(CH3)3, KOC(CH3)3, K2CO3, Na2CO3, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), 1,5-diazabicyclo[4.3.0]non-5-ene (DBN), tri(C1-C4alkyl)amine, pyridine and n-butyllithium.

[0119] The first alkali may be sodium hydroxide in particular. Based on 100 parts by weight of the L-homoserine derivative represented by Chemical Formula 6, the content of the first alkali may be, for example, 0.1 to 100 parts by weight, 0.1 to 50 parts by weight, 0.1 to 40 parts by weight, 0.1 to 30 parts by weight, 0.1 to 20 parts by weight, 0.1 to 10 parts by weight, 0.1 to 5 parts by weight, or 0.1 to 2 parts by weight. When the content of the first alkali is too low, the effect on the reaction rate may be small, and when the content of the first alkali is too much, by-products may increase. The step of preparing the third intermediate compound of Chemical Formula 7 may be carried out under a solvent. The solvent may be water or an organic solvent. When the first alkali is used and the solvent is water, the pH value of the aqueous solution containing water may be 9 to 14, 10 to 14, or 12 to 14. Since the pH value of the reaction solution is within this range, L-homoserine-based compounds can be prepared more easily. In the step of preparing L-homoserine-based compounds, the functional group transfer reaction may be carried out at a temperature of, for example, 20 to 150°C. In the step of preparing the L-homoserine-based compound, the functional group transfer reaction can be performed for, for example, 0.1 to 20 hours. Since the functional group transfer reaction is performed within the above temperature range and time range, the third intermediate compound can be prepared more easily.

[0120] In the step of preparing the third intermediate compound, the yield of the third intermediate compound can be, for example, 10% or more, 20% or more, 30% or more, 40% or more, 50% or more, 60% or more, 70% or more, 80% or more, 90% or more, 95% or more, 96% or more, 97% or more, 98% or more, or 99% or more.

[0121] In the step of preparing the third intermediate compound, the enantiomeric excess of the third intermediate compound can be, for example, 10% ee or more, 20% ee or more, 30% ee or more, 40% ee or more, 50% ee or more, 60% ee or more, 70% ee or more, 80% ee or more, 90% ee or more, 91% ee or more, 92% ee or more, 93% ee or more, 94% ee or more, 95% ee or more, 96% ee or more, 97% ee or more, 98% ee or more, or 99% ee or more.

[0122] Next, the third intermediate compound represented by Chemical Formula 7 may react with a third acid to prepare a compound represented by Chemical Formula 1.

[0123] That is, the third intermediate compound represented by Chemical Formula 7 may react with the third acid to be lactonized to prepare a lactone compound represented by the following Chemical Formula 1. For example, the third intermediate compound represented by Chemical Formula 7 may form a lactone ring by the third acid.

[0124] <Chemical Formula 7>

[0125]

[0126] <Chemical Formula 1>

[0127]

[0128] The third acid may be, for example, at least one selected from the group consisting of acetic acid, HCl, H 2 SO 4 , HBr, and HI.

[0129] The content of the third acid can be appropriately selected according to the type of acid used. For example, relative to the first intermediate compound represented by chemical formula 4, the third acid can be used in an amount of 0.1 equivalent or more. Specifically, in the case of hydrochloric acid or sulfuric acid, it can be 0.1 to 2 equivalents, 0.3 to 1.8 equivalents or 0.5 to 1.5 equivalents, and in the case of acetic acid, it can be 10 equivalents or more, 20 equivalents or more, 10 equivalents to 50 equivalents or 20 to 40 equivalents. When the content of the third acid is too low, the impact on the reaction rate may be small, and when the content of the third acid is too high, by-products may increase.

[0130] The step of preparing the compound of Chemical Formula 1 may be carried out in the presence of a solvent, or may be carried out in a pure condition without a solvent. The solvent may be water or an organic solvent.

[0131] In the step of preparing the compound of Chemical Formula 1, the lactone-forming reaction may be performed at a temperature of, for example, 20 to 150° C. In the step of preparing the first intermediate compound, the lactone-forming reaction may be performed for, for example, 0.1 to 20 hours. Since the lactone-forming reaction is performed within the above temperature range and time range, the compound of Chemical Formula 1 may be prepared more easily.

[0132] In the step of preparing the compound of Chemical Formula 1, the yield of the compound of Chemical Formula 1 can be, for example, 10% or more, 20% or more, 30% or more, 40% or more, 50% or more, 60% or more, 70% or more, 80% or more, 90% or more, 95% or more, 96% or more, 97% or more, 98% or more, or 99% or more.

[0133] In the step of preparing the compound of Chemical Formula 1, the enantiomeric excess of the first intermediate compound having the L form may be, for example, 10% ee or more, 20% ee or more, 30% ee or more, 40% ee or more, 50% ee or more, 60% ee or more, 70% ee or more, 80% ee or more, 90% ee or more, 91% ee or more, 92% ee or more, 93% ee or more, 94% ee or more, 95% ee or more, 96% ee or more, 97% ee or more, 98% ee or more, or 99% ee or more.

[0134] The present invention is described in more detail below in conjunction with the following embodiments and comparative examples. However, these embodiments are only for illustrative purposes, and the scope of the present invention is not limited thereto.

[0135] Example 1: Preparation of L-phosphinothricin using N-acetyl-L-homoserine lactone (using the second intermediate compound (1))

[0136] (Step 1-1: Preparation of ethyl 2-(acetylamino)-4-chlorobutyrate)

[0137]

[0138] To a solution of 4 g (28 mmol) of N-acetyl-L-homoserine lactone dissolved in 60 mL of ethanol at 0°C, thionyl chloride (6.6 g, 56 mmol) was slowly added to prepare a reaction solution. The prepared reaction solution was stirred at 80°C for 3 hours. Then, 1N NaOH (aq) was added to the reaction-completed solution for neutralization, and then concentrated under reduced pressure to prepare a concentrated solution. The prepared concentrated solution was diluted with ethyl acetate and then washed once with brine. The organic layer was dried over anhydrous magnesium sulfate (MgSO4), filtered, and the filtrate was concentrated under reduced pressure to obtain a residue containing ethyl 2-(acetylamino)-4-chlorobutyrate.

[0139] The obtained residue was separated by column chromatography (mobile phase, hexane:ethyl acetate=1:1) to obtain 5.12 g (yield 88%) of ethyl 2-(acetylamino)-4-chlorobutyrate as a colorless oil.

[0140] 1 H NMR (400MHz, DMSO-d6): δ4.49(m,1H),4.22(q,2H),3.60(t,2H),2.25(m,2H),1.91(s,3H),1.30(t,3H)

[0141] (Step 1-2: Preparation of ethyl 2-(acetylamino)-4(ethoxymethylphosphinyl)butanoate)

[0142]

[0143] After dissolving 2-(acetylamino)-4-chlorobutyric acid ethyl ester (2.6g, 12.6mmol) and diethyl methylphosphinate (3.4g, 25.2mmol, 2 equivalents), nitrogen was introduced and stirred for 12 hours at 120°C. After the reaction was completed, unreacted diethyl methylphosphinate was removed under a reduced pressure of 80°C and 1mmHg. By column chromatography (mobile phase, ethyl acetate: isopropanol=4:1 volume ratio), the obtained residue was separated to obtain 2.25g (yield 64%) 2-(acetylamino)-4 (ethoxymethylphosphinyl) butyric acid ethyl ester, which was a colorless oil.

[0144] 1 H NMR (400MHz, CDCl3): δ4.40(m,1H),4.20(q,2H),3.99(q,2H),2.01(m,4H),1.91(s,3H),1.45(d,J=14Hz,3H),1.30(t,3H),1.26(t,3H).31P NMR (CDCl3, 121.47MHz) δ 54.28.

[0145] (Step 1-3: Preparation of L-phosphinothricin (L-phosphinothricin) hydrochloride)

[0146]

[0147] 2 g (7.17 mmol) of ethyl 2-(acetylamino)-4-(ethoxymethylphosphinyl)butanoate was dissolved in 20 mL of 6N HCl, placed in a sealed tube, and stirred at 120° C. for 15 hours. After the hydrolysis reaction was completed, the solvent was removed under reduced pressure to obtain 1.49 g of white L-phosphinothricin hydrochloride (yield 96%; total yield of steps 1-1 to 1-3 61%).

[0148] 1 H NMR (400MHz, D2O): δ4.12 (m, 1H), 2.45-1.65 (m, 4H), 1.46 (d, J = 14Hz, 3H).

[0149] Reference Example 1: Preparation of N-acetyl-L-homoserine lactone

[0150]

[0151] To an aqueous solution in which O-acetyl-L-homoserine (II) (1 g, 6.2 mmol) was dissolved in 30 mL of water, NaOH (40 wt.% aqueous solution) was slowly added as an alkali catalyst to prepare a reaction solution with a pH of 9. Then, the prepared reaction solution was stirred at 25° C. for 30 minutes. Then, the reaction solution was heated to 50° C. and stirred at 50° C. for 5 hours. Then, 1N HCl (aq) was added to the reaction-completed solution for neutralization, and then concentrated under reduced pressure to prepare a concentrated solution. After the prepared concentrated solution was cooled to 0° C., ethanol was added thereto, the mixture was stirred, and filtered under reduced pressure to obtain 0.98 g (yield 98%) of N-acetyl-L-homoserine (III-1) as a white solid.

[0152] 1 H NMR (400MHz, DMSO-d6): δ7.68(d,J=8Hz,1H),3.96(m,1H),3.40(t,J=6.8Hz,2H),1.83(s,3H),1.81(m,1H),1.61(m,1H)

[0153]

[0154] In an aqueous solution in which O-acetyl-L-homoserine (1 g, 6.2 mmol) was dissolved in 30 mL of water, c-HCl (concentrated hydrochloric acid) was slowly added as an acid to prepare a reaction solution with a pH of 2. The prepared reaction solution was stirred at 25° C. for 30 minutes. Then, the reaction solution was heated to 60° C. and then stirred at 60° C. for 3 hours. Then, 1N NaOH (aq) was added to the reaction-completed solution for neutralization, and then concentrated under reduced pressure to prepare a concentrated solution. The prepared concentrated solution was cooled to 0° C., and then isopropanol was added thereto, the mixture was stirred, and filtered under reduced pressure to obtain 0.87 g (yield 98%) of N-acetyl-L-homoserine lactone as a white solid.

[0155] 1 H NMR (400MHz, DMSO-d6): δ3.96(m,1H),3.89(t,J=6.8Hz,2H),1.91(s,3H),2.11(m,1H),1.83(m,1H)

[0156] Example 2: Preparation of L-phosphinothricin using N-succinyl-L-homoserine lactone (using the second intermediate compound (2))

[0157] (Step 2-1: Preparation of ethyl 2-(succinylamino)-4-chlorobutyrate)

[0158]

[0159] Ethyl 2-(succinylamino)-4-chlorobutyrate was prepared in the same manner as in Example 1 using N-succinyl-L-homoserine lactone.

[0160] Subsequently, white L-glufosinate hydrochloride was obtained from ethyl 2-(succinylamino)-4-chlorobutyrate in the same manner as in Example 1 (total yield of 4 steps (step 1-2 and step 1-3) 51%).

[0161] 1 H NMR (400MHz, D2O): δ4.12 (m, 1H), 2.45-1.65 (m, 4H), 1.46 (d, J = 14Hz, 3H).

[0162] Reference Example 2: Preparation of N-succinyl-L-homoserine lactone

[0163]

[0164] To an aqueous solution prepared by dissolving O-succinyl-L-homoserine (1 g, 4.57 mmol) in 30 mL of water, NaOH (40 wt.% aqueous solution) was slowly added to prepare a reaction solution with a pH of 9.

[0165] Then, the prepared reaction solution was stirred at 25°C for 30 minutes. Then, the reaction solution was heated to 50°C and stirred at 50°C for 5 hours. Then, 1N HCl (aq) was added to the reaction completed solution for neutralization, and then concentrated under reduced pressure to prepare a concentrated solution. After the prepared concentrated solution was cooled to 0°C, ethanol was added thereto, the mixture was stirred, and filtered under reduced pressure. Thus, 0.98 g (yield 98%) of N-succinyl-L-homoserine was obtained as a white solid.

[0166] 1 H NMR (400MHz, DMSO-d6): δ7.68(d,J=8Hz,1H),3.96(m,1H),3.40(t,J=6.8Hz,2H) ,2.55(t,J=13Hz,H),2.31(t,J=13Hz,2H),1.83(s,3H),1.81(m,1H),1.61(m,1H)

[0167]

[0168] In an aqueous solution in which N-succinyl-L-homoserine (1 g) was dissolved in 30 mL of water, c-HCl (concentrated hydrochloric acid) was slowly added as an acid to prepare a reaction solution with a pH of 2. The prepared reaction solution was stirred at 25° C. for 30 minutes. Then, the reaction solution was heated to 60° C. and then stirred at 60° C. for 3 hours. Then, 1N NaOH (aq) was added to the reaction-completed solution for neutralization, and then concentrated under reduced pressure to prepare a concentrated solution. The prepared concentrated solution was cooled to 0° C., ethanol was added thereto, the mixture was stirred, and filtered under reduced pressure to obtain (yield 98%) N-succinyl-L-homoserine lactone as a white solid.

[0169] 1 H NMR (400MHz, DMSO-d6): δ3.96 (m, 1H), 3.89 (t, J = 6.8 Hz, 2H), 2.45 (t, J = 13 Hz, 2H), 2.31 (t, J = 13 Hz, 2H), 1.81 (m, 1H), 1.61.

[0170] Example 3: Preparation of L-phosphinothricin using N-acetyl-L-homoserine lactone (without using the second intermediate compound) (1))

[0171] (Step 3-1: Preparation of ethyl 2-(acetylamino)-4(ethoxymethylphosphinyl)butanoate)

[0172]

[0173] 1.8 g (12.6 mmol) of N-acetyl-L-homoserine lactone was dissolved in 20 mL of ethanol, and then diethyl methylphosphite (3.4 g, 25.2 mmol, 2 equivalents) and trimethylsilyl iodide (5.0 g, 25.2 mmol, 2 equivalents) were placed in a sealed tube, nitrogen was introduced, and then stirred at 140°C for 14 hours.

[0174] After the reaction was completed, unreacted diethyl methylphosphinate was removed at 80° C. and 1 mmHg under reduced pressure. The resulting residue was separated by column chromatography (mobile phase, ethyl acetate:isopropanol=4:1 volume ratio) to obtain 4.42 g (yield 62.8%) of ethyl 2-(acetylamino)-4(ethoxymethylphosphinyl)butanoate as a colorless oil.

[0175] 1 H NMR (400MHz, CDCl3): δ4.40(m,1H),4.20(q,2H),3.99(q,2H),2.01(m,4H),1.91(s,3H),1.45(d,J=14Hz,3H),1.30(t,3H),1.26(t,3H). 31 P NMR (CDCl3, 121.47MHz) δ 54.28.

[0176] (Step 3-2: Preparation of L-phosphinothricin (L-phosphinothricin) hydrochloride)

[0177]

[0178] 2 g (7.17 mmol) of ethyl 2-(acetylamino)-4-(ethoxymethylphosphinyl)butanoate was dissolved in 20 mL of 6N HCl, placed in a sealed tube, and stirred at 120° C. for 15 hours. After the hydrolysis reaction was completed, the solvent was removed under reduced pressure to obtain 1.49 g (yield 96%) of white L-phosphinothricin hydrochloride.

[0179] 1 H NMR (400MHz, D2O): δ4.12 (m, 1H), 2.45-1.65 (m, 4H), 1.46 (d, J = 14Hz, 3H).

[0180] Example 4: Preparation of L-phosphinothricin using N-succinyl-L-homoserine lactone (without using the second intermediate compound) Object (2))

[0181] (Step 4-1: Preparation of ethyl 2-(succinylamino)-4(ethoxyphosphinyl)butanoate)

[0182]

[0183] Ethyl 2-(succinylamino)-4-(ethoxyphosphinyl)butanoate was prepared in the same manner as in Example 1 using N-succinyl-L-homoserine lactone.

[0184] Subsequently, ethyl 2-(succinylamino)-4-(ethoxyphosphinyl)butanoate was hydrolyzed in the same manner as in Example 1 to obtain white L-phosphinothricin hydrochloride (yield 96%).

[0185] Comparative Example 1: Preparation of racemic glufosinate

[0186] Glufosinate was prepared according to the method disclosed in Example 1 of USP 6,359,162. The prepared glufosinate was a racemic mixture.

[0187] Comparative Example 2: Comparison with the method for producing L-phosphinothricin by introducing a protective group into homoserine lactone

[0188] In order to compare the preparation method and reaction results of L-glufosinate by introducing a protecting group into homoserine lactone, L-glufosinate was prepared according to the following reaction scheme 1.

[0189] [Reaction Scheme 1]

[0190]

[0191] The reaction conditions and reaction results of each reaction step are shown in Table 1 below.

[0192] [Table 1]

[0193]

[0194]

[0195] (OAHS: O-acetylhomoserine, HSL: homoserine lactone, NecHSL: N-ethoxycarbonylhomoserine lactone, Cl-NecHSL-OEt: 2-(ethoxycarbonylamino)-4-chlorobutyric acid ethyl ester, P-NecHSL-OEt: 2-(ethoxycarbonylamino)-4-(ethoxymethylphosphinyl)butyric acid ethyl ester)

[0196] As shown in Table 1, when hydrochloric acid is used to prepare a lactone compound from an L-homoserine derivative, a homoserine lactone shown in Reaction Scheme 1 is obtained. The homoserine lactone is obtained, the amine group in the homoserine lactone is protected with an ethoxycarbonyl group, halogenated with a halogenating agent, combined with a phosphorus compound, and then hydrolyzed to prepare L-phosphinothricin. Thus, it is confirmed that L-phosphinothricin is obtained in a low yield.

[0197] Experimental Example 1: Determination of enantiomeric excess (%ee)

[0198] The enantiomeric excess of L-glufosinate synthesized in Examples 1 to 4 and Comparative Example 1 was determined using chiral HPLC, and the results are shown in Table 2 below.

[0199] Chiral HPLC analysis was performed with reference to the method disclosed in J. Chromatogr. 368, 413 (1986).

[0200] Use Sumichiral OA6100 (4.6×150mm), The enantiomeric excess (%ee) was determined using an OD-H (4.6×250 mm), Sumichiral OA5000 (4.6×150 mm) or Chiralpak zwix (4.0×150 mm) chiral column. The mobile phase used a co-solvent of 0-30% methanol, 0-70% acetonitrile and 0-70% distilled water or a 2 mM copper sulfate aqueous solution, the solvent flow rate was 1.0 mL / min, the sample injection volume was 10 μL, and the ultraviolet (UV) detection wavelength was 200 nm to 280 nm.

[0201] [Table 2]

[0202] Classification Enantiomeric excess [%ee] Example 1 94 Example 2 94 Example 3 94 Example 4 94 Comparative Example 1 Less than 1

[0203] As shown in Table 2, in the case of glufosinate prepared in Examples 1 to 4, the enantiomeric excess of L-glufosinate is significant compared to the glufosinate prepared in Comparative Example 1, and therefore, L-glufosinate can be simply prepared with high purity by the preparation method involving the intermediate compound of the present invention.

[0204] Reference Example 1: pH when preparing the L-homoserine compound represented by Chemical Formula 7 from an L-homoserine derivative Conditional study

[0205] The pH-dependent acquisition of the L-homoserine-based compound represented by Chemical Formula 7 from the L-homoserine derivative represented by Chemical Formula 6 was confirmed. By using the L-homoserine derivative O-acetyl-L-homoserine as a starting material, the L-homoserine-based compound N-acetyl-L-homoserine was obtained in the same manner as the preparation method of Reference Example 1 (Steps 1-4), provided that the pH during the reaction became 8.2, 9.2, 10.2, 12.7, and 13.4, respectively. The results are shown in Table 3 below.

[0206] [Table 3]

[0207] Reaction conditions Reaction results 8.2 NAHS 12.2% / OAHS 87.8% 9.2 NAHS 50.8% / OAHS 49.2% 10.2 NAHS 93.9% / OAHS 6.1% 12.7 NAHS 100% / OAHS 0% 13.4 NAHS 100% / OAHS 0%

[0208] (OAHS: O-acetyl-L-homoserine, NAHS: N-acetyl-L-homoserine)

[0209] As shown in Table 3, when the L-homoserine-based compound represented by Chemical Formula 7 was prepared from the L-homoserine derivative represented by Chemical Formula 6, the yield of N-acetyl-L-homoserine increased with increasing pH, and particularly when the pH was 9 or higher, N-acetyl-L-homoserine was obtained in high yield.

[0210] Reference Example 2: Study on pH conditions when preparing the first intermediate compound from L-homoserine compounds

[0211] The preparation of the lactone compound represented by Chemical Formula 1 from the L-homoserine-based compound represented by Chemical Formula 7 according to the reaction conditions was confirmed. By using N-acetyl-L-homoserine as the homoserine-based compound, the compound N-acetyl-L-homoserine lactone represented by Chemical Formula 1 was obtained in the same manner as the preparation method of Reference Example 1 (Step 1-5), provided that the equivalent of the acid and the reaction temperature during the reaction were changed as shown in Tables 4 to 6, respectively, and the results are shown in Tables 4 to 6 below.

[0212] [Table 4]

[0213]

[0214]

[0215] (NAHS: N-acetyl-L-homoserine, NAASL: N-acetyl-L-homoserine lactone)

[0216] As shown in Table 4, when the compound represented by Chemical Formula 1 was prepared from the L-homoserine-based compound represented by Chemical Formula 7 using acetic acid, the yield of N-acetyl-L-homoserine lactone increased with the increase of acetic acid equivalent, and particularly when the acetic acid equivalent was 2.6 or more, N-acetyl-L-homoserine lactone was obtained in high yield.

[0217] As the reaction temperature increases, the yield of N-acetyl-L-homoserine lactone increases, and particularly when the reaction temperature is 40° C. or higher, N-acetyl-L-homoserine lactone is obtained in high yield.

[0218] [Table 5]

[0219]

[0220] As shown in Table 5, when the compound of Chemical Formula 1 was prepared from the L-homoserine-based compound represented by Chemical Formula 7 using hydrochloric acid, the yield of N-acetyl-L-homoserine lactone increased as the hydrochloric acid equivalent increased to 1.0, while the yield of N-acetyl-L-homoserine lactone gradually decreased when 1.5 equivalents or more of hydrochloric acid was applied.

[0221] [Table 6]

[0222]

[0223] As shown in Table 6, when the compound of Chemical Formula 1 was prepared from the L-homoserine-based compound represented by Chemical Formula 7 using sulfuric acid, the yield of N-acetyl-L-homoserine lactone increased as the sulfuric acid equivalent increased to 1.0, while the yield of N-acetyl-L-homoserine lactone gradually decreased when 1.5 equivalents or more of sulfuric acid was applied.

[0224] Experimental Example 2: Study on the reaction conditions for preparing the first intermediate compound from the compound of Chemical Formula 1

[0225] The conditions for obtaining the first intermediate compound represented by Chemical Formula 4 from the compound of Chemical Formula 1 according to the reaction conditions were confirmed. By using N-acetyl-L-homoserine lactone as the compound of Chemical Formula 1, the first intermediate compound 2-(acetylamino)-4-chlorobutyric acid ethyl ester or 2-(acetylamino)-4-chlorobutyric acid methyl ester was obtained in the same manner as in Example 1 (Step 1-1), provided that the equivalent of ethanol or methanol during the reaction and the reaction temperature were as shown in Tables 7 and 8 below, respectively, and the results were also as shown in Tables 7 and 8 below.

[0226] [Table 7]

[0227]

[0228] (NAHSL: N-acetyl-L-homoserine lactone, Cl-NAHS-OEt: 2-(acetylamino)-4-chlorobutyric acid ethyl ester)

[0229] As shown in Table 7, when ethanol is used to prepare the first intermediate compound represented by Chemical Formula 4 from the compound of Chemical Formula 1, the yield of ethyl 2-(acetylamino)-4-chlorobutyrate increases with the increase of ethanol equivalents, especially when the ethanol equivalents are 3 to 10 equivalents, ethyl 2-(acetylamino)-4-chlorobutyrate is obtained in high yield.

[0230] As the reaction temperature increases, the yield of ethyl 2-(acetylamino)-4-chlorobutyrate increases, especially when the reaction temperature is 40° C. or higher, ethyl 2-(acetylamino)-4-chlorobutyrate is obtained in high yield.

[0231] [Table 8]

[0232]

[0233] (NAHSL: N-acetyl-L-homoserine lactone, Cl-NAHS-OMe: 2-(acetylamino)-4-chlorobutyric acid methyl ester)

[0234] As shown in Table 8, when methanol is used to prepare the first intermediate compound represented by Chemical Formula 4 from the compound of Chemical Formula 1, the yield of methyl 2-(acetylamino)-4-chlorobutyrate increases with the increase of methanol equivalents. In particular, when the methanol equivalent is 3 to 10 equivalents, methyl 2-(acetylamino)-4-chlorobutyrate is obtained in high yield.

[0235] As the reaction temperature increases, the yield of methyl 2-(acetylamino)-4-chlorobutyrate increases, especially when the reaction temperature is 40° C. or higher, methyl 2-(acetylamino)-4-chlorobutyrate is obtained in high yield.

[0236] Experimental Example 3: Study on the reaction conditions for preparing the second intermediate compound from the first intermediate compound

[0237] The second intermediate compound represented by Chemical Formula 2 was obtained by the first intermediate compound represented by Chemical Formula 4 according to the reaction conditions. The second intermediate compound was obtained by the same method as the preparation method of Example 1 (Step 1-2), except that 2-(acetylamino)-4-chlorobutyric acid ethyl ester was used as the first intermediate compound, and the equivalent and type of the phosphorus compound in the reaction process and the reaction temperature were changed as shown in Table 9, respectively, and the results are also shown in Table 9.

[0238] [Table 9]

[0239]

[0240]

[0241] (DMP: diethyl methylphosphite, EMP: ethyl methylphosphite, BMP: butyl methylphosphite, P-NAHS-Oet: ethyl 2-(acetylamino)-4(ethoxymethylphosphinyl)butanoate)

[0242] As shown in Table 9, using AMP (alkyl methylphosphinate) (e.g., DMP or EMP or BMP) as the phosphorus-based compound, the second intermediate compound represented by Chemical Formula 2 can be prepared from the first intermediate compound represented by Chemical Formula 4, and when 1 equivalent or more of DMP or AMP is used, the yield is further increased. As the reaction temperature increases, the yield is further increased, and in particular, at 120° C. or higher, ethyl 2-(acetylamino)-4-(ethoxymethylphosphinyl)butanoate is obtained in high yield.

[0243] Experimental Example 4: Study on the reaction conditions for preparing the second intermediate compound from the compound of Chemical Formula 1

[0244] The second intermediate compound represented by Chemical Formula 2 was obtained from the compound of Chemical Formula 1 according to the reaction conditions. The second intermediate compound was obtained by using N-acetyl-L-homoserine lactone as the compound of Formula 1 in the same manner as the preparation method of Example 2 (Step 2-1), provided that the equivalent and type of the halogenating agent and the reaction temperature during the reaction were changed as shown in Tables 10 to 12, respectively, and the results are also shown in Tables 10 to 12.

[0245] [Table 10]

[0246]

[0247]

[0248]

[0249] [Table 11]

[0250]

[0251] [Table 12]

[0252]

[0253]

[0254] (TMSI: trimethylsilyl iodide, TMSBr: trimethylsilyl bromide, TMSCl: trimethylsilyl chloride, P-NAHS-Oet: ethyl 2-(acetylamino)-4(ethoxymethylphosphinyl)butanoate)

[0255] As shown in Tables 10 to 12, trimethylsilyl halide (e.g., TMSI, TMSBr, or TMSCl) or NaI can be used as a halogenating agent to prepare the second intermediate compound represented by Chemical Formula 2 from the compound of Chemical Formula 1. When 0.5 equivalents or more of trimethylsilyl halide is used, the yield is further increased. As the reaction temperature increases, the yield is further increased, particularly at 100° C. or higher, ethyl 2-(acetylamino)-4-(ethoxymethylphosphinyl)butanoate is obtained in high yield.

[0256] Among the trimethylsilyl halides, TMSI is the most reactive, and the reactivity tends to be lower in the order of TMSBr and TMSCl, but all can give ethyl 2-(acetylamino)-4-(ethoxymethylphosphinyl)butyrate.

[0257] Experimental Example 5: Reaction Conditions of L-phosphinothricin Ammonium of the Second Intermediate Compound

[0258] The acquisition of the second intermediate compound represented by Chemical Formula 2 according to the reaction conditions was confirmed. By using ethyl 2-(acetylamino)-4-(ethoxymethylphosphinyl)butyrate as the second intermediate compound, L-phosphinothricin was obtained in the same manner as the preparation method of Example 1 (Steps 1-3), provided that the acid used, the reaction temperature and the reaction time were changed as shown in Table 13 below, respectively, and the results are shown in Table 13.

[0259] [Table 13]

[0260]

[0261] As shown in Table 13, by using 6N hydrochloric acid as an acid, L-phosphinothionyl ammonium can be prepared from the second intermediate compound represented by Chemical Formula 2 at 120°C, and the yield tends to increase further with the increase of reaction time. In addition, it is confirmed that when the reaction is carried out for more than 15 hours, the yield increases further with the increase of reaction temperature.

Claims

1. A method for preparing L-glufosinate-ammonium, which is a method for preparing L-glufosinate-ammonium from an L-lactone derivative compound, comprising: The step of preparing the compound of the following Chemical Formula 2 from the compound of the following Chemical Formula 1, i.e., step a; and a step of preparing L-phosphinothionylamine of the following chemical formula 3 from the compound of the chemical formula 2, i.e., step b, Wherein, the step a comprises a step of preparing the compound of the chemical formula 2 by reacting the compound of the chemical formula 1 with a halogenating agent, at least one R2-OH and a compound of the following chemical formula 5, i.e., step a-1, wherein the compound of Chemical Formula 1 is prepared from a fermentation broth containing a precursor of the compound of Chemical Formula 1 by the following reaction: reacting the precursor of Chemical Formula 6 with a base selected from the group consisting of NH3, KOH, NaOH, CaSO4, LiOH, NaH, KH, NaOCH3, NaOCH2CH3, NaOC(CH3)3, KOC(CH3)3, K2CO3, Na2CO3, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), 1,5-diazabicyclo[4.3.0]non-5-ene (DBN), tri(C1-C4 alkyl)amine, pyridine and n-butyllithium to obtain a compound of Chemical Formula 7, and then reacting the compound of Chemical Formula 7 with an acid selected from the group consisting of acetic acid, HCl, H2SO4, HBr and HI to obtain the compound of Chemical Formula 1; Based on 1 equivalent of the compound of Chemical Formula 1, the content of the compound of Chemical Formula 5 is 0.5 to 10 equivalents; The step a-1 is performed at a temperature of 80 to 180° C. for 0.1 to 20 hours; The step b is carried out at a temperature of 20 to 150° C. for 0.1 to 30 hours: Chemical formula 1 Chemical formula 2 Chemical formula 3 Chemical formula 5 Chemical formula 6 Chemical formula 7 In the formula, R1 is acetyl or succinyl, R2 is a substituted or unsubstituted alkyl group having 1 to 6 carbon atoms, R3 and R4 are independently substituted or unsubstituted alkyl groups having 1 to 6 carbon atoms, R5 is a substituted or unsubstituted alkyl group having 1 to 6 carbon atoms, and the substituent of the alkyl group is at least one selected from the group consisting of hydrogen, halogen, carboxyl (-COOH), amino (-NH2), nitro (-NO2), cyano (-CN), alkyl groups having 1 to 6 carbon atoms, aryl groups having 6 to 10 carbon atoms, and cycloalkyl groups having 3 to 10 carbon atoms.

2. The method for preparing L-phosphinothricin according to claim 1, wherein The R2 is any one selected from the group consisting of methyl, ethyl, propyl, butyl, pentyl and hexyl.

3. The method for preparing L-phosphinothricin according to claim 1, wherein The R3 and R4 are independently any one selected from the group consisting of methyl, ethyl, propyl, butyl, pentyl and hexyl.

4. The method for preparing L-phosphinothricin-ammonium according to claim 1, wherein The halogenating agent comprises at least one selected from the group consisting of HCl, HBr, HI, phosgene, SOCl2, oxalyl chloride, trimethylsilyl halide, sodium iodide (NaI), triethylsilane ((CH2CH3)3SiH)+palladium chloride (PdCl2)+methyl iodide (CH3I), POCl3, PCl3, PCl5, PBr3, PI3, H2SO4+KBr, P+Cl2, P+Br2, P+I2, TiCl4, ZnCl2 and BBr3.

5. The method for preparing L-phosphinothricin ammonium according to claim 1, wherein The R2-OH comprises at least one selected from the group consisting of methanol, ethanol, n-propanol, isopropanol, butanol, pentanol and hexanol.

6. The method for preparing L-phosphinothricin ammonium according to claim 1, wherein: The content of R2-OH is 1 to 60 equivalents based on 1 equivalent of the compound of Chemical Formula 1.

7. The method for preparing L-phosphinothricin ammonium according to claim 1, wherein: The halogenating agent may be included in an amount of 0.1 to 10 equivalents based on 1 equivalent of the compound of Chemical Formula 1.

8. The method for preparing L-phosphinothricin ammonium according to claim 1, wherein: The compound of Chemical Formula 5 includes any one selected from the group consisting of diethyl methylphosphite (DMP), ethyl methylphosphite (EMP), and butyl methylphosphite (BMP).

9. The method for preparing L-phosphinothricin ammonium according to claim 1, wherein: The step b is carried out by hydrolyzing the compound of Chemical Formula 2 in the presence of an acid catalyst.

10. The method for preparing L-glufosinate-ammonium according to claim 9, wherein: The acid catalyst comprises at least one selected from the group consisting of acetic acid, HCl, H2SO4 and KF-Al2O3.

11. The method for preparing L-glufosinate-ammonium according to claim 1, further comprising preparing the L-glufosinate-ammonium into a salt form thereof, wherein: The salt of L-glufosinate is selected from at least one of the hydrochloride of L-glufosinate, the sulfate of L-glufosinate, the carbonate of L-glufosinate, the sodium salt of L-glufosinate and the ammonium salt of L-glufosinate.

Citation Information

Patent Citations

  • The method for producing bio-based homoserinelactone and bio-based organic acid from O-acylhomoserine by microorganism

    KR1020140116010A

  • Method for synthesizing L-glufosinate-ammonium intermediate (S)-3-amino-gamma-butyrolactone hydrochloride, and application of method

    CN106045947A

  • Refined glufosinate preparation method

    CN106083922A

  • Process for the preparation of phosphorus-containing L-amino acids, their derivatives and intermediates for this process

    US5442088A